Implantica

swiss medtech company at the forefront of ehealth and smart medical implants with initial focus on urology and digestive surgery. management with a very successful track record in the implant business - developed the gastric band business to 28% non-us market share ce marked implant refluxstop™ - potential for a paradigm shift in anti-reflux surgery - ce mark obtained in q3 2018 after clinical trial with excellent and remarkable results wireless disruptive energizing platform and ehealth platform technology, e-invivo™. remote-controlled implants powered wirelessly through intact skin and ehealth applications niche with focus on actions inside the body huge ip portfolio with >1,000 patents and an impressive r&d pipeline >300 individual inventions - covering multiple aspects of the product, its application and method of use - 40 pipeline implants selected